Crossmark

Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana

Crossref DOI link: https://doi.org/10.1186/s12936-021-03693-3

Published Online: 2021-03-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amenga-Etego, Lucas N. http://orcid.org/0000-0003-4468-0506
Asoala, Victor

Agongo, Godfred

Jacob, Christopher

Goncalves, Sonia

Awandare, Gordon A.

Rockett, Kirk A.

Kwiatkowski, Dominic
Funding

Funding for this research was provided by:

Wellcome Trust (206194, 090770/Z/09/Z)

Medical Research Council and Department for International Developmen (G0600718, M006212)

DELGEME Aspiring Leader (107740/z/15/z)
License Information

Text and Data Mining valid from 2021-03-17

Version of Record valid from 2021-03-17
More Information

Article History

Received: 26 November 2020

Accepted: 6 March 2021

First Online: 17 March 2021

Declarations

:

: The study was conducted in accordance with the principles and Declaration of Helsinki (1964) as amended in 2015. Ethical approval was obtained from the Institutional Review Board of the Navrongo Health Research Centre (NHRCIRB203). Informed consent was obtained from all adult participants and assent/parental consent for children and minors obtained through their parents or Caregivers.

: All authors have consented for publication.

: The authors declare that they have no competing interest.

Document is current

Any future updates will be listed below